What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It means replacing hormones (estrogen, progesterone, testosterone, etc.) with preparations whose molecular structure matches the hormones your body makes. BHRT is used to treat symptoms of hormone deficiency (most commonly menopausal symptoms). Whether you “need” it depends on your symptoms, medical history, and risk factors — that decision should be made with a clinician.

What BHRT is and how it differs from conventional HRT

• Bioidentical: the active molecules (e.g., 17β‑estradiol, micronized progesterone) are chemically identical to human hormones.
• Delivery: available as pills, patches, creams/gels, vaginal rings/tablets, injections, or compounded preparations.
• FDA‑approved vs compounded: Some bioidentical formulations are FDA‑approved (e.g., estradiol patches, micronized progesterone) and have standardized dosing and safety data. “Compounded BHRT” is customized by compounding pharmacies and is less regulated — quality and dosing can vary.

Common reasons people consider BHRT

• Menopausal vasomotor symptoms (hot flashes, night sweats)
• Genitourinary syndrome of menopause (vaginal dryness, painful sex, recurrent UTIs)
• Severe sleep disturbance, mood symptoms, loss of libido (sometimes)
• Premature ovarian insufficiency or surgical menopause
• Low testosterone in men (testosterone replacement is standard when indicated)

How to know if you might need BHRT

1. Look at symptoms: classic menopausal symptoms (hot flashes, night sweats, vaginal dryness) are the main indications. If these are moderate to severe and interfering with life, hormone therapy is a reasonable option.
2. Medical evaluation: see a clinician (gynecologist, primary care, or endocrinologist experienced in menopause). They will:
   • Review your symptoms and medical/family history (breast cancer, blood clots, stroke, heart disease).
   • Do a physical exam and recommend appropriate screening (mammogram, pelvic exam).
   • Order targeted labs if needed (e.g., FSH/estradiol in some cases; testosterone if considering replacement). Routine saliva hormone tests are not recommended to guide therapy.
3. Risk/benefit discussion: BHRT has benefits (symptom relief, improved quality of life; local vaginal estrogen is safe and effective for urogenital symptoms) but also risks similar to conventional hormone therapy (increased risk of blood clots, stroke, and, with some combined regimens, a small increased risk of breast cancer depending on type and duration). Age and years since menopause matter — starting around the time of menopause (generally <10 years or <60 years old) has a different risk profile than starting much later.

Who should generally avoid systemic hormone therapy

• Current or recent breast cancer (unless cleared by oncology)
• Active or recent blood clots (venous thromboembolism)
• Unexplained vaginal bleeding
• Active liver disease
• Known high risk for cardiovascular disease without careful evaluation

Products and services (examples)

• FDA‑approved bioidentical options (regulated, standardized):
  • Estradiol patches: Vivelle‑Dot, Climara — for systemic estrogen replacement.
  • Oral estradiol: Estrace (estradiol tablets).
  • Vaginal/local options for GU symptoms: Vagifem (vaginal estradiol tablets), Estring (vaginal ring) — effective for dryness/urgency without substantial systemic exposure.
  • Micronized progesterone: Prometrium — bioidentical progesterone used when a uterus is present to protect the endometrium.
  • For men’s testosterone: AndroGel, Testim — FDA‑approved preparations for male hypogonadism. (Testosterone for women is an off‑label, specialist‑supervised consideration.)
• Testing services: reputable labs like Quest Diagnostics or Labcorp for baseline bloodwork.
• Provider resources: The North American Menopause Society (NAMS) offers evidence‑based guidance and a provider locator for clinicians who specialize in menopause care.

What to watch out for

• Compounded BHRT is sometimes marketed as safer or more “natural.” Because compounding pharmacies are less regulated, products can vary in dose and purity — use only accredited compounding pharmacies (PCAB accreditation) and a prescriber who understands the limitations.
• Avoid relying on saliva hormone panels to diagnose menopause or guide dosing; they are unreliable for most indications.

Next steps

1. If you have bothersome menopausal symptoms, make an appointment with a clinician experienced in menopause care.
2. Bring a symptom list and your medical/family history.
3. Expect a discussion of benefits/risks, baseline screening, and a trial of the simplest effective option (local vaginal estrogen for urogenital symptoms; lowest effective systemic dose for hot flashes, with regular follow‑up).

If you want, tell me your age, symptoms, and medical history (any personal/family history of breast cancer, blood clots, heart disease, or stroke), and I can give more tailored guidance on whether BHRT might be appropriate and what type to discuss with a clinician.